Cancer Causes & Control

, Volume 20, Issue 8, pp 1261–1269 | Cite as

Family history of various cancers and pancreatic cancer mortality in a large cohort

  • Eric J. Jacobs
  • Carmen Rodriguez
  • Christina C. Newton
  • Elizabeth B. Bain
  • Alpa V. Patel
  • Heather Spencer Feigelson
  • Michael J. Thun
  • Eugenia E. Calle
Original Paper


A family history of pancreatic cancer is associated with increased risk of pancreatic cancer, but uncertainty remains about the magnitude of this association, whether it varies by age or smoking and whether a family history of other cancers may also be associated with increased risk. We examined family history of 14 cancers and pancreatic cancer mortality among ~1.1 million men and women in Cancer Prevention Study-II (CPS-II). CPS-II participants completed a questionnaire at enrollment in 1982. During follow-up through 2006, there were 7,306 pancreatic cancer deaths. A family history of pancreatic cancer in a parent or sibling was associated with pancreatic cancer mortality [multivariable adjusted rate ratio (RR) = 1.66, 95% confidence interval (CI) 1.43–1.94]. This association was stronger among participants aged under 60 (RR = 2.89, 95% CI 1.67–5.02) than among participants aged 60 or older (RR = 1.61, 95% CI 1.37–1.88). Weaker associations were observed for family history of stomach cancer (RR = 1.23, 95% CI 1.11–1.37), liver cancer (RR = 1.25, 95% CI 1.10–1.43), and colorectal cancer (RR = 1.12, 95% CI 1.01–1.23). Results from this large prospective study indicate family history of pancreatic cancer is associated with a moderate increase in risk of pancreatic cancer, and also identify associations with the family history of certain other cancers which may be useful in generating hypotheses about shared risk factors.


Pancreatic cancer Family history Pancreatic neoplasms Cohort study Epidemiology 


  1. 1.
    Goldgar DE, Easton DF, Cannon-Albright LA, Skolnick MH (1994) Systematic population-based assessment of cancer risk in first-degree relatives of cancer probands. J Natl Cancer Inst 86(21):1600–1608. doi: 10.1093/jnci/86.21.1600 PubMedCrossRefGoogle Scholar
  2. 2.
    Coughlin SS, Calle EE, Patel AV, Thun MJ (2000) Predictors of pancreatic cancer mortality among a large cohort of United States adults. Cancer Causes Control 11:915–923. doi: 10.1023/A:1026580131793 PubMedCrossRefGoogle Scholar
  3. 3.
    Hemminki K, Li X (2003) Familial and second primary pancreatic cancers: a nationwide epidemiologic study from Sweden. Int J Cancer 103(4):525–530. doi: 10.1002/ijc.10863 PubMedCrossRefGoogle Scholar
  4. 4.
    Amundadottir LT, Thorvaldsson S, Gudbjartsson DF, Sulem P, Kristjansson K, Arnason S et al (2004) Cancer as a complex phenotype: pattern of cancer distribution within and beyond the nuclear family. PLoS Med 1(3):e65. doi: 10.1371/journal.pmed.0010065 PubMedCrossRefGoogle Scholar
  5. 5.
    Fernandez E, La Vecchia C, D’Avanzo B, Negri E, Franceschi S (1994) Family history and the risk of liver, gallbladder, and pancreatic cancer. Cancer Epidemiol Biomarkers Prev 3(3):209–212PubMedGoogle Scholar
  6. 6.
    Silverman DT, Schiffman M, Everhart J, Goldstein A, Lillemoe KD, Swanson GM et al (1999) Diabetes mellitus, other medical conditions and familial history of cancer as risk factors for pancreatic cancer. Br J Cancer 80(11):1830–1837. doi: 10.1038/sj.bjc.6690607 PubMedCrossRefGoogle Scholar
  7. 7.
    Schenk M, Schwartz AG, O’Neal E, Kinnard M, Greenson JK, Fryzek JP et al (2001) Familial risk of pancreatic cancer. J Natl Cancer Inst 93(8):640–644. doi: 10.1093/jnci/93.8.640 PubMedCrossRefGoogle Scholar
  8. 8.
    Ghadirian P, Liu G, Gallinger S, Schmocker B, Paradis AJ, Lal G et al (2002) Risk of pancreatic cancer among individuals with a family history of cancer of the pancreas. Int J Cancer 97(6):807–810. doi: 10.1002/ijc.10123 PubMedCrossRefGoogle Scholar
  9. 9.
    McWilliams RR, Rabe KG, Olswold C, De Andrade M, Petersen GM (2005) Risk of malignancy in first-degree relatives of patients with pancreatic carcinoma. Cancer 104(2):388–394. doi: 10.1002/cncr.21166 PubMedCrossRefGoogle Scholar
  10. 10.
    Hassan MM, Bondy ML, Wolff RA, Abbruzzese JL, Vauthey JN, Pisters PW et al (2007) Risk factors for pancreatic cancer: case–control study. Am J Gastroenterol 102(12):2696–2707. doi: 10.1111/j.1572-0241.2007.01510.x PubMedCrossRefGoogle Scholar
  11. 11.
    Del Chiaro M, Zerbi A, Falconi M, Bertacca L, Polese M, Sartori N et al (2007) Cancer risk among the relatives of patients with pancreatic ductal adenocarcinoma. Pancreatology 7(5–6):459–469. doi: 10.1159/000108963 PubMedCrossRefGoogle Scholar
  12. 12.
    Poole CA, Byers T, Calle EE, Bondy J, Fain P, Rodriguez C (1999) Influence of a family history of cancer within and across multiple sites on patterns of cancer mortality risk for women. Am J Epidemiol 149(5):454–462PubMedGoogle Scholar
  13. 13.
    Habbe N, Langer P, Sina-Frey M, Bartsch DK (2006) Familial pancreatic cancer syndromes. Endocrinol Metab Clin North Am 35(2):417–430. doi: 10.1016/j.ecl.2006.02.016 PubMedCrossRefGoogle Scholar
  14. 14.
    Couch FJ, Johnson MR, Rabe KG, Brune K, de Andrade M, Goggins M et al (2007) The prevalence of BRCA2 mutations in familial pancreatic cancer. Cancer Epidemiol Biomarkers Prev 16(2):342–346. doi: 10.1158/1055-9965.EPI-06-0783 PubMedCrossRefGoogle Scholar
  15. 15.
    Geary J, Sasieni P, Houlston R, Izatt L, Eeles R, Payne SJ et al (2008) Gene-related cancer spectrum in families with hereditary non-polyposis colorectal cancer (HNPCC). Fam Cancer 7(2):163–172. doi: 10.1007/s10689-007-9164-6 PubMedCrossRefGoogle Scholar
  16. 16.
    Stellman SD, Garfinkel L (1986) Smoking habits and tar levels in a new American Cancer Society prospective study of 1.2 million men and women. J Natl Cancer Inst 76:1057–1063PubMedGoogle Scholar
  17. 17.
    Calle EE, Terrell DD (1993) Utility of the national death index for ascertainment of mortality among Cancer Prevention Study II participants. Am J Epidemiol 137:235–241PubMedGoogle Scholar
  18. 18.
    World Health Organization (1977) International classification of diseases: manual of the international statistical classification of diseases, injuries, and causes of death, vol 1. World Health Organization, Geneva (Switzerland) 9th RevisionGoogle Scholar
  19. 19.
    Fesinmeyer MD, Austin MA, Li CI, De Roos AJ, Bowen DJ (2005) Differences in survival by histologic type of pancreatic cancer. Cancer Epidemiol Biomarkers Prev 14(7):1766–1773. doi: 10.1158/1055-9965.EPI-05-0120 PubMedCrossRefGoogle Scholar
  20. 20.
    Cox DR (1972) Regression models and life tables (with discussion). J R Stat Soc (B) 34:187–220Google Scholar
  21. 21.
    Kleinbaum DG (1996) Survival analysis: a self-learning text. Springer, New YorkGoogle Scholar
  22. 22.
    Hemminki K, Li X (2001) Familial colorectal adenocarcinoma and hereditary nonpolyposis colorectal cancer: a nationwide epidemiological study from Sweden. Br J Cancer 84:969–974. doi: 10.1054/bjoc.2000.1718 PubMedCrossRefGoogle Scholar
  23. 23.
    Raymond J, Thiberg JM, Chevalier C, Kalach N, Bergeret M, Labigne A et al (2004) Genetic and transmission analysis of Helicobacter pylori strains within a family. Emerg Infect Dis 10(10):1816–1821PubMedGoogle Scholar
  24. 24.
    Miyazaki M, Kato M, Takata T, Une H (2002) Intrafamilial transmission of Helicobacter pylori: the association between a parent and an offspring with respect to the presence of anti-CagA antibody. J Infect Chemother 8(1):70–75PubMedGoogle Scholar
  25. 25.
    Helicobacter and Cancer Collaborative Group (2001) Gastric cancer and Helicobacter pylori: a combined analysis of 12 case control studies nested within prospective cohorts. Gut 49(3):347–353CrossRefGoogle Scholar
  26. 26.
    Raderer M, Wrba F, Kornek G, Maca T, Koller DY, Weinlaender G et al (1998) Association between Helicobacter pylori infection and pancreatic cancer. Oncology 55(1):16–19. doi: 10.1159/000011830 PubMedCrossRefGoogle Scholar
  27. 27.
    Stolzenberg-Solomon RZ, Blaser MJ, Limburg PJ, Perez-Perez G, Taylor PR, Virtamo J et al (2001) Helicobacter pylori seropositivity as a risk factor for pancreatic cancer. J Natl Cancer Inst 93(12):937–941. doi: 10.1093/jnci/93.12.937 PubMedCrossRefGoogle Scholar
  28. 28.
    de Martel C, Llosa AE, Friedman GD, Vogelman JH, Orentreich N, Stolzenberg-Solomon RZ et al (2008) Helicobacter pylori infection and development of pancreatic cancer. Cancer Epidemiol Biomarkers Prev 17(5):1188–1194. doi: 10.1158/1055-9965.EPI-08-0185 PubMedCrossRefGoogle Scholar
  29. 29.
    Aarnio M, Sankila R, Pukkala E, Salovaara R, Aaltonen LA, de la Chapelle A et al (1999) Cancer risk in mutation carriers of DNA-mismatch-repair genes. Int J Cancer 81(2):214–218. doi: 10.1002/(SICI)1097-0215(19990412)81:2<214::AID-IJC8>3.0.CO;2-L PubMedCrossRefGoogle Scholar
  30. 30.
    Thorlacius S, Sigurdsson S, Bjarnadottir H, Olafsdottir G, Jonasson JG, Tryggvadottir L et al (1997) Study of a single BRCA2 mutation with high carrier frequency in a small population. Am J Hum Genet 60(5):1079–1084PubMedGoogle Scholar
  31. 31.
    Johannesdottir G, Gudmundsson J, Bergthorsson JT, Arason A, Agnarsson BA, Eiriksdottir G et al (1996) High prevalence of the 999del5 mutation in icelandic breast and ovarian cancer patients. Cancer Res 56(16):3663–3665PubMedGoogle Scholar
  32. 32.
    Lal G, Liu G, Schmocker B, Kaurah P, Ozcelik H, Narod SA et al (2000) Inherited predisposition to pancreatic adenocarcinoma: role of family history and germ-line p16, BRCA1, and BRCA2 mutations. Cancer Res 60(2):409–416PubMedGoogle Scholar
  33. 33.
    Thorlacius S, Olafsdottir G, Tryggvadottir L, Neuhausen S, Jonasson JG, Tavtigian SV et al (1996) A single BRCA2 mutation in male and female breast cancer families from Iceland with varied cancer phenotypes. Nat Genet 13(1):117–119. doi: 10.1038/ng0596-117 PubMedCrossRefGoogle Scholar
  34. 34.
    Murff HJ, Spigel DR, Syngal S (2004) Does this patient have a family history of cancer? An evidence-based analysis of the accuracy of family cancer history. Jama 292(12):1480–1489. doi: 10.1001/jama.292.12.1480 PubMedCrossRefGoogle Scholar
  35. 35.
    Calle EE, Rodriguez C, Jacobs EJ, Almon ML, Chao A, McCullough ML et al (2002) The American Cancer Society cancer prevention study II nutrition cohort—rationale, study design and baseline characteristics. Cancer 94:2490–2501. doi: 10.1002/cncr.101970 PubMedCrossRefGoogle Scholar
  36. 36.
    Ries LAG, Eisner MP, Kosary CL, Hankey BF, Miller BA, Clegg L et al (eds) (2002) SEER Cancer Statistics Review, 1973–1999. National Cancer Institute, BethesdaGoogle Scholar

Copyright information

© Springer Science+Business Media B.V. 2009

Authors and Affiliations

  • Eric J. Jacobs
    • 1
  • Carmen Rodriguez
    • 1
  • Christina C. Newton
    • 1
  • Elizabeth B. Bain
    • 1
  • Alpa V. Patel
    • 1
  • Heather Spencer Feigelson
    • 1
  • Michael J. Thun
    • 1
  • Eugenia E. Calle
    • 1
  1. 1.Department of Epidemiology, Epidemiology and Surveillance ResearchAmerican Cancer SocietyAtlantaUSA

Personalised recommendations